Insider Transactions

What GeoVax Labs Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Spencer John N Jr	Director	Oct 17	Open-market buy · P	+10,000	$0.55	+$5.5K	21,402
McKee Kelly T. Jr.	Chief Medical Officer	Aug 07	Open-market buy · P	+1,107	$0.67	+$742	3,494
Sharkey John W.	VP, Business Development	Apr 10	Open-market buy · P	+6,000	$0.99	+$5.94K	6,191
Spencer John N Jr	Director	Apr 10	Open-market buy · P	+10,000	$0.98	+$9.8K	11,402
Dodd David A	President, CEO	Apr 01	Open-market buy · P	+10,000	$1.08	+$10.8K	36,661
Reynolds Mark	CFO	Mar 31	Open-market buy · P	+6,800	$1.08	+$7.34K	14,013
Dodd David A	President, CEO	Aug 09	Open-market buy · P	+8,000	$1.95	+$15.6K	26,661
Dodd David A	President, CEO	Feb 22	Open-market buy · P	+8,209	$2.27	+$18.7K	18,661
Dodd David A	President, CEO	Feb 21	Open-market buy · P	+520	$2.15	+$1.12K	10,452
Reynolds Mark	CFO	Feb 07	Open-market buy · P	+2,000	$2.77	+$5.54K	7,213
McKee Kelly T. Jr.	Chief Medical Officer	Dec 22	Open-market buy · P	+6,944	$0.36	+$2.5K	35,782
McKee Kelly T. Jr.	Chief Medical Officer	Sep 25	Open-market buy · P	+9,653	$0.52	+$5.02K	28,838
Dodd David A	President, CEO	Aug 25	Open-market buy · P	+35,087	$0.57	+$20K	148,957
Reynolds Mark	CFO	Aug 18	Open-market buy · P	+10,000	$0.52	+$5.18K	78,184
Dodd David A	President, CEO	Apr 24	Open-market buy · P	+32,000	$0.64	+$20.4K	113,870
Reynolds Mark	CFO	Apr 20	Open-market buy · P	+8,000	$0.63	+$5.04K	68,184
Chase Randal D	Director	Sep 21	Open-market buy · P	+10,000	$1.10	+$11K	36,613
Sharkey John W.	VP, Business Development	Jul 01	Open-market buy · P	+1,000	$0.82	+$820	2,860
McKee Kelly T. Jr.	Chief Medical Officer	Jun 27	Open-market buy · P	+4,464	$1.12	+$5K	19,185
Chase Randal D	Director	Jun 21	Open-market buy · P	+10,000	$1.21	+$12.1K	26,613

Page 1 of 8 · showing the 20 most recent Sign up free to view all 144 transactions and filter by insider →

Comments